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Treating Aortic Stenosis and Mitral Regurgitation
With 1 Transcatheter Heart Valve
2 Birds With 1 Stone
William M. Suh, MD,* Gabriel Vorobiof, MD,* Richard J. Shemin, MD,y
Murray H. Kwon, MD,y Melissa Fusari, MD,z Jonathan M. Tobis, MD*
Los Angeles and Irvine, Californian 82-year-old woman with severe aortic stenosis and left ventricular ejection fractionA(LVEF) of 20% was referred for transcatheter aortic valve replacement (TAVR). Aorticregurgitation was moderate (A, Online Video 1), mean gradient was 38mmHg (B), mitral
regurgitation (MR) was severe (C, Online Video 2), and the LVwasmarkedly dilated to 251ml (D).
TAVR with a 23-mm Edwards Sapien valve was performed with cardiopulmonary bypass for
hemodynamic stability during valve implantation. After TAVR, there was trace central aortic
regurgitation (E), mean gradient was reduced to 9 mm Hg (F), MR disappeared completely
(G, Online Video 3), and LV volume was reduced to 168 ml (H) with an LVEF of 30%.
TAVR relieved the pressure and volume overload within the LV, with dramatic acute effects on
LV performance. The immediate reversal in MR proved that the MR was functional due to
dilation of the LV and its effects on the mitral valve annulus and apparatus. TAVR successfully
eliminated 2 valvular abnormalities.
